In addition, overall patients’ survival analysis according to LIFR and LIF combined expression showed that high expression of both in diffuse type GC leads to better prognosis than low expression, and the same trend is observed for intestinal type GC, though not significant. The gene discussed is LIFR; the disease is gastric cancer.